Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
about
Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individualsBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependencePharmacological therapies for maintenance treatments of opium dependenceOpioid dependency in pregnancy and length of stay for neonatal abstinence syndromeThe law (and politics) of safe injection facilities in the United StatesDihydrocodeine for detoxification and maintenance treatment in illicit opiate-dependent individualsOpioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaUse of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary careMethadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysisEffectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for UkraineCost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersHCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, ChinaMultilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDSCost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in MalaysiaEffectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemicsA review of a national training initiative to increase provider use of MAT to address the opioid epidemic.Five-factor model personality traits in opioid dependenceSomatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort studyEvaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysisThe journey of opioid substitution therapy in India: Achievements and challenges.Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatmentGender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaintsOpioid dependence treatment: options in pharmacotherapy.Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatmentCan we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial.Costs of care for persons with opioid dependence in commercial integrated health systems.Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practiceHealth-related quality of life changes associated with buprenorphine treatment for opioid dependence.Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.Can Primary Care Clinic Run MMT Service Well?Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action.Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir/indinavir.Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.Buprenorphine: new treatment of opioid addiction in primary care.Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia.Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States
P2860
Q21203511-11A44736-1B32-49E0-B1C5-FD69C10D6A24Q24200539-2FCF8471-07A9-4CDC-AAD3-43C481078D4AQ24201615-13188A54-4CA5-4054-9314-4F839C376BB3Q24628765-8611E92D-24ED-4BBB-BC0D-5EFF52FAEB1EQ24657290-1A2DF884-D47C-41CC-BC5F-997BB913EE10Q26471618-3C43EEA3-0B52-46CD-BE2C-1B9CF17EF8D9Q26778626-3E65BBD6-BD5F-410D-9537-49443187EA27Q28081029-BB08C9BE-C1D2-4CA0-A863-E7BEE01B950AQ28087193-B4254C20-B743-4ECA-87E3-95AF59012246Q28477312-F9EBE5BF-97E4-4001-B863-2977AEDB9218Q28483820-4564FF61-76B7-4DDE-A580-AEDAA988C9A5Q28483942-3C1E9895-222C-436C-B6A1-DE56CFBA1BB3Q28484316-86CDD376-F7B0-45DE-9B0A-54ECA8325A82Q28485456-57ECE316-DD83-48AB-94EB-E4DA23868A48Q28539234-3E761591-7AA5-43FB-9F3E-BF642D109423Q30239840-CBFE6347-98B8-4626-8D3E-AE9DB72D2358Q33293441-F303A89E-7388-4723-9427-DE7EECEE1CABQ33317649-45FC2883-6BF4-4059-8B5D-47CB7253C89EQ33574968-B7A606C2-6DC5-4548-BD37-BE26F08E272AQ33612388-CD8913B2-04A1-43FE-921A-6FDF085DF391Q33641636-87C1E508-98F1-4B39-AE09-FCEC7124FD9DQ33673067-A36AC851-1173-4954-BA14-0BA3738F3BC3Q33807411-188F599C-5078-42E2-99BA-D7DEC5F6BA08Q33811199-F12B877C-B287-433E-B24C-B32AF5BD64C2Q33868638-6FE78925-3760-4029-AD3D-E2A2B6E0A802Q33977281-107E1C85-23B5-42E3-B851-DB8A5F80B3EFQ34041421-281F42AF-BB7A-4EB3-9989-04E9D749D21CQ34079752-7E3F7C3F-FA4D-46EC-94D7-2D2E4E840B1AQ34113771-8305EF30-CA20-4880-A76D-EE56959B1D00Q34129263-A0983032-0865-423F-843B-3D6985F6B3D9Q34216585-B68C84E4-D0C3-4A0E-B95C-FDF7ABDFCC17Q34220752-95939B19-8935-423F-82DB-668F4F50E0F4Q34411910-9BFD8D18-7495-4B0A-B990-EE09F9FB144DQ34452695-06EDD15F-55D2-4BF1-BFE5-D0F4BB27A00DQ34604652-EE6D91F5-EFDA-44FC-B6E6-E9BA0C3A6F7DQ34615753-65BADDAA-6107-421A-804D-334673506510Q34667890-64A38878-CA34-4206-94A4-51E1B48B2520Q34953130-55FF8B45-5FBE-4299-94B2-5F8976377A5DQ35043378-7800C4CF-6A56-450C-96B2-5380122AEB3AQ35058786-D0ECBF83-7108-4995-9384-0E96DC95623B
P2860
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Methadone and buprenorphine fo ...... eview and economic evaluation.
@ast
Methadone and buprenorphine fo ...... eview and economic evaluation.
@en
Methadone and buprenorphine fo ...... eview and economic evaluation.
@nl
type
label
Methadone and buprenorphine fo ...... eview and economic evaluation.
@ast
Methadone and buprenorphine fo ...... eview and economic evaluation.
@en
Methadone and buprenorphine fo ...... eview and economic evaluation.
@nl
prefLabel
Methadone and buprenorphine fo ...... eview and economic evaluation.
@ast
Methadone and buprenorphine fo ...... eview and economic evaluation.
@en
Methadone and buprenorphine fo ...... eview and economic evaluation.
@nl
P2093
P356
P1476
Methadone and buprenorphine fo ...... review and economic evaluation
@en
P2093
A Fry-Smith
A Juarez-Garcia
N Lintzeris
R J Taylor
R S Taylor
P304
1-171, iii-iv
P356
10.3310/HTA11090
P50
P577
2007-03-01T00:00:00Z